Answers are grounded in this paper and cite their sources.
Proteomic profiling shows probiotics improve IGFBP expression in malnourished mice, suggesting growth support.
Malnutrition disrupts the insulin-like growth factor (IGF) axis, impairing systemic growth and brain function. This study quantitatively assessed IGF-binding protein (IGFBP) expression in the liver and brain of malnourished mice following probiotic supplementation. Male BALB/c mice were subjected to a low-protein diet to induce malnutrition, then divided into probiotic and control groups. Proteomic profiling using the Mouse XL Cytokine Array (R&D Systems, ARY028) revealed organ-specific differences. In the liver, probiotics markedly increased IGFBP-3 (net intensity 3000 AU) and reduced IGFBP-1 (1200 AU) compared with malnourished controls, while maintaining IGFBP-2 (2500 AU). In the brain, probiotics induced IGFBP-5 (1,800 AU) and IGFBP-6 (1,500 AU), both of which were absent in controls, alongside a moderate IGFBP-2 signal (2,200 AU). These quantitative findings indicate that probiotics selectively enhance hepatic IGF-1 stabilization via IGFBP-3 while promoting neurotrophic support through IGFBP-5 and IGFBP-6. The results highlight the potential of probiotics as an adjunctive strategy to restore growth and neurological function in malnutrition.
No takes yet. Share an insight, caveat, or question.
Sulastri et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: